Akero Therapeutics (AKRO) Tops Q1 EPS by 11c

Akero Therapeutics (NASDAQ: AKRO) reported Q1 EPS of ($0.90), $0.11 better than the analyst estimate of ($1.01).

For earnings history and earnings-related data on Akero Therapeutics (AKRO) click here.

You May Also Be Interested In

• FedEx falls 4% as FY2027 profit forecast misses expectations despite Q4 beat
• Cerebras Systems posts 94% revenue jump, announces OpenAI deal
• Rocky Mountain Chocolate Factory (RMCF) files $6M mixed shelf